Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro.

Qiuxia LinHua ZouXian ChenMenglu WuDeyu MaHanbing YuSiqiang NiuShi-Feng Huang

Published in: BMC microbiology (2021)

AVI potentiated the activity of both CAZ and ATM against S. maltophilia clinical isolates in vitro. We demonstrated that CAZ-AVI and ATM-AVI are both useful therapeutic options to treat infections caused by S. maltophilia.

Keyphrases

dna damage
dna repair
dna damage response
gram negative